LEMAITRE VASCULAR DL -,01 Logo
US5255582018
A0LB2B
LMAT

LEMAITRE VASCULAR DL -,01

Loading quotes...

Forecast

The analysts' average price target is €102.81 (+40.84%). The median is €102.81 (+40.84%).

Buy
  14
Hold
  6
Sell
  0

  • LeMaitre Vascular reaches 52-week low at $78.64

    LeMaitre Vascular's stock fell to a 52-week low of $78.64 and is currently trading just above that level. In the second quarter the company reported adjusted earnings of $0.74 per share and revenue of $70.4 million, missing analysts' expectations; the annual growth forecast was revised downward. The stock is down about 17% year-to-date, while ratings from InvestingPro classify the stock as undervalued and highlight financial health as "VERY GOOD" and a PEG of 0.71. » More on de.investing.com


  • LeMaitre Vascular shares fall after profit taking despite strong quarter

    LeMaitre Vascular reported a strong quarter with 10% organic revenue growth, 72.1% gross margins and adjusted EPS of $0.68, beating the $0.66 consensus. Despite solid fundamentals, the stock declined after the earnings release as investors took profits following a prior YTD gain of about 38%. Conestoga Capital Advisors highlighted the company in its Q2 letter and remains confident in LeMaitre Vascular’s ability to drive revenue and earnings growth going forward. » More on finance.yahoo.com


  • LeMaitre Vascular slips to 52-week low at $79.38 after Q2 miss

    LeMaitre Vascular’s shares fell to a 52‑week low of $79.38 after the company missed consensus estimates for the second quarter. LeMaitre reported adjusted earnings of $0.74 per share on revenue of $70.4 million (expectations: $0.81 and $71.47 million) and subsequently cut its full‑year growth forecast. Despite the setback, the stock is up nearly 25% year‑on‑year and more than 31% year‑to‑date; analysts have price targets between $100 and $135. The company, with a market capitalization of $1.81 billion, is currently trading below its fair‑value estimate, suggesting upside potential. » More on de.investing.com

Historical dividends Dividends

All dividend metrics All metrics
In 2026, LEMAITRE VASCULAR DL -,01 has already paid €0.65 in dividends. The last payout was in September.

Financials

In the last quarter, LEMAITRE VASCULAR DL -,01 had revenue of €61.67m and net profit of €14.94m
(EUR) June 2026
YoY
Revenue 61.67m 13.16%
Gross profit 44.48m 16.57%
Net profit 14.94m 27.79%
EBITDA 17.5m 6.33%

Fundamentals

Metric Value
Market capitalization
€1.66bn
Number of shares
22.87m
52-week high/low
€105.50 - €69.93
Dividend yield
1.13%
Dividends TTM
€0.82
Beta
0.47
P/E ratio
28.02
PEG ratio
0.74
P/B ratio
4.42
P/S ratio
7.08

Company profile

LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. It offers angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries or veins; occlusion catheters that temporarily occlude the blood flow; perfusion catheters to perfuse the blood and other fluids into the vasculature; and thrombectomy catheters, which features a silicone balloon for removing thrombi in the venous system. The company also provides carotid shunts that temporarily shunt the blood to the brain during the removal of plaque from the carotid artery in a carotid endarterectomy surgery; and radiopaque tape, a medical-grade tape applied to the skin that enables interventionists to cross-refer between the inside and the outside of a patient's body, and allows them to locate tributaries or lesions beneath the skin. In addition, it offers valvulotomes, which cut or disrupt valves in the saphenous vein to function as an artery to carry blood past diseased arteries to the lower leg or the foot; and vascular grafts to bypass or replace diseased arteries. Further, the company provides vascular and cardiac patches, which are used for closure of vessels after surgical intervention; and closure systems to attach vessels to one another with titanium clips instead of sutures. It markets its products through a direct sales force and distributors. The company was formerly known as Vascutech, Inc. and changed its name to LeMaitre Vascular, Inc. in April 2001. LeMaitre Vascular, Inc. was incorporated in 1983 and is headquartered in Burlington, Massachusetts.

Name
LEMAITRE VASCULAR DL -,01
CEO
George W. LeMaitre
Headquarters Burlington, ma
USA
Website
Sector
Health Care
Industry
Health Care Equipment & Supplies
IPO
19/10/2006
Employees 651

Ticker symbols

Exchange Symbol
NASDAQ
LMAT
Frankfurt
LHU.F
DĂĽsseldorf
LHU.DU
MĂĽnchen
LHU.MU
🍪

Parqet  uses cookies. Learn more